Apalutamide、阿帕鲁胺是一种非甾体类抗雄激素药物，与第一代药物相比，它以7至10倍的亲和力直接结合雄激素受体的配体结合结构域。它是一种选择性和竞争性雄激素受体抑制剂。

Apalutamide is a non-steroidal anti-androgen drug that binds directly to the androgen receptor ligand binding domain with 7 to 10 times greater affinity than first-generation drugs. It is a selective and competitive androgen receptor inhibitor.

阿帕鲁胺

　　阿帕鲁胺也是改变历史，是第一款用于医治非转移性去势抵抗性前列腺癌（nm-CRPC）及转移性去势敏感性的前列腺癌（mCSPC）的治疗药物,碧康制药生产制造的Apalunix是阿帕鲁胺在全球性的首仿药，该仿制药是孟加拉药监局获批上市的合规药物。

Path amine and change history, is the first used to heal the metastatic castration resistant prostate cancer (nm - CRPC) and metastatic castration (mCSPC) in the treatment of prostate cancer drug sensitivity, brigitte kang pharmaceutical manufacturing Apalunix is path amine in global the first copy of medicine, food and drug administration approved the generic drug is Bangladesh listed drug compliance.